Jounce Announces Presentation At The Leerink Partners Immuno-Oncology Roundtable

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jounce Therapeutics, Inc., a company focused on the discovery and development of novel cancer immunotherapies coupled to patient selection strategies, today announced that Richard Murray, Ph.D., chief executive officer, will present a company overview at the Leerink Partners Immuno-Oncology Roundtable on Thursday, October 1, 2015, at 1:30 p.m. ET. The conference is being held at the Le Parker Meridien Hotel in New York City.

Help employers find you! Check out all the jobs and post your resume.

Back to news